| Product Details | |
| Generic Name | Sunitinib |
| Strength | 12.5mg |
| Medicine Form | Capsules |
| Manufactured By | Aprazer Pharma |
| Quantity | 28 Capsules |
| Packaging Type | Bottle |
Sutekast Sunitinib 12.5mg capsules are a targeted therapy medication designed to combat various types of cancers. Each capsule contains 12.5mg of sunitinib, a potent inhibitor of multiple receptor tyrosine kinases involved in cancer progression and angiogenesis.
Usage: These capsules are primarily prescribed for the treatment of:
- Advanced renal cell carcinoma (kidney cancer)
- Progressive pancreatic neuroendocrine tumors (pNET)
- Unresectable or metastatic gastrointestinal stromal tumors (GIST)
Mechanism of Action: Sunitinib works by blocking signals within cancer cells that promote their growth. It targets specific proteins and receptors on cancer cells and blood vessels that support tumor growth, thereby inhibiting their ability to proliferate and metastasize.
Dosage and Administration: Typically, patients are instructed to take Sutekast Sunitinib capsules orally once daily, preferably at the same time each day. Dosage adjustments may be made by healthcare providers based on individual patient response and tolerance to the medication.
Important Considerations:
- It is crucial to follow the prescribed dosage and administration schedule strictly.
- Some common side effects may include fatigue, diarrhea, nausea, and skin discoloration.
- Patients should inform their healthcare provider about any other medications they are taking, including over-the-counter drugs and supplements, to avoid potential interactions.
Storage: Store Sutekast Sunitinib capsules at room temperature away from light and moisture. Keep out of reach of children and pets.
